FDA approves Duplex system for Cefepime delivery

The FDA has approved the use of B. Braun Medical's Duplex drug delivery system for delivery of FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP. Cefepine is used in hospitals and healthcare centers to treat a wide variety of bacterial infections.

"Making 1g and 2g Cefepime available to healthcare workers in the Duplex drug delivery system gives them another weapon to combat challenging infections with speed, safety and accuracy," says Rob Albert, B. Braun Medical VP of Marketing.

The Duplex system is a ready-to-use, two-compartment container that stores pre-measured pharmaceuticals and diluent doses. It can be stored at room temperature with 18-month minimum dating and fits in automated medication dispensing systems. Healthcare workers fold and squeeze the container, shaking it to mix the pharmaceuticals and diluent. A barcode that references the final admixture, lot number and expiration date helps reduce medication errors, automate patient charting, track inventory and facilitate reimbursement tracking.

- take a look at B. Braun's release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.